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While the association between exposure to secondhand smoke and lung cancer risk is well established, few studies with suffi-
cient power have examined the association by histological type. In this study, we evaluated the secondhand smoke-lung can-
cer relationship by histological type based on pooled data from 18 case–control studies in the International Lung Cancer
Consortium (ILCCO), including 2,504 cases and 7,276 control who were never smokers and 10,184 cases and 7,176 controls
who were ever smokers. We used multivariable logistic regression, adjusting for age, sex, race/ethnicity, smoking status,
pack-years of smoking, and study. Among never smokers, the odds ratios (OR) comparing those ever exposed to secondhand
smoke with those never exposed were 1.31 (95% CI: 1.17–1.45) for all histological types combined, 1.26 (95% CI: 1.10–1.44)
for adenocarcinoma, 1.41 (95% CI: 0.99–1.99) for squamous cell carcinoma, 1.48 (95% CI: 0.89–2.45) for large cell lung can-
cer, and 3.09 (95% CI: 1.62–5.89) for small cell lung cancer. The estimated association with secondhand smoke exposure
was greater for small cell lung cancer than for nonsmall cell lung cancers (OR52.11, 95% CI: 1.11–4.04). This analysis is the
largest to date investigating the relation between exposure to secondhand smoke and lung cancer. Our study provides more
precise estimates of the impact of secondhand smoke on the major histological types of lung cancer, indicates the association
with secondhand smoke is stronger for small cell lung cancer than for the other histological types, and suggests the impor-
tance of intervention against exposure to secondhand smoke in lung cancer prevention.
Lung cancer, with 1.59 million deaths in 2012, is the most
common cause of cancer death worldwide.1 Active tobacco
smoking has been established as a strong risk factor for lung
cancer, with an average risk ratio (RR) of 15–30.2 Smoking is
associated with increased risks of all major histological types of
lung cancer, although it has been reported to be more strongly
associated with small cell lung cancer (odds ratio [OR] 5 12.9,
95% conﬁdence interval [CI]: 9.79–17.1) and squamous cell
carcinoma (OR 5 11.3, 95% CI: 9.39–13.5) than with large cell
lung cancer (OR 5 5.64, 95% CI: 4.15–7.67) and adenocarci-
noma (OR 5 3.22, 95% CI: 2.62–3.98).3 However, about 25%
of the world’s lung cancer cases are not attributable to active
tobacco use.4 Even if lung cancer cases among never smokers
are considered separately from those among ever smokers, lung
cancer among never smokers ranks as the seventh most com-
mon cause of cancer death worldwide.4
The development of lung cancer in never smokers has
stimulated myriad investigations on potential risk factors for
What’s new?
Lung cancer is the most common cause of cancer death worldwide, and it’s often caused by smoking tobacco. Even if you
only count people who have never smoked, lung cancer would still rank seventh, in part because of exposure to environmental
tobacco smoke. This study sought to tease out how secondhand smoke affected risk of each different lung cancer type. By
pooling data from 18 case-control studies, the authors determined that exposure to secondhand smoke increased the risk of
small-cell lung cancer more than any other type.
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lung cancer among those populations. Based on its review of
numerous studies, the International Agency for Research on
Cancer (IARC) concluded that involuntary smoking is carci-
nogenic to humans, with an increased risk of 20% for women
and of 30% for men among never smokers who are exposed
to secondhand smoke (i.e., environmental tobacco smoke)
from their spouse.5 Based on an analysis of 37 epidemiologi-
cal studies, Hackshaw et al. reported never smokers who
lived with a smoker were at a 26% increased risk of lung can-
cer when compared with those who did not live with a
smoker (95% CI: 6–47%).6 Dose–response relationships were
observed between lung cancer risk and both the number of
cigarettes smoked by the spouse and the duration of expo-
sure. The pooled relative risk was higher for squamous and
small cell carcinoma (RR 5 1.58, 95% CI: 1.14–2.19) than
for adenocarcinoma (RR 5 1.25, 95% CI: 1.07–1.46). Simi-
larly, a pooled analysis of two case–control studies reported
that duration of exposure showed consistent dose–response
relationships with adenocarcinoma and squamous and small
cell carcinomas and suggested a higher risk for squamous
and small cell carcinomas than for adenocarcinoma.7 How-
ever, this previous analysis was limited by inadequate power
for further analysis by each histological type of lung cancer.
In most of the studies to date, the number of small cell lung
cancer cases among never smokers has been too small to be
studied in detail.8–10
In this study, we aim to investigate the relationship
between exposure to secondhand smoke and risk of lung can-
cer by histological type (adenocarcinoma, squamous cell car-
cinoma, large cell lung cancer, and small cell lung cancer)
among ever smokers and never smokers combined and
among never smokers only, using the pooled database of the
International Lung Cancer Consortium (ILCCO).
Material and Methods
Study population
ILCCO was established in 2004 with the objective of sharing
comparable data from ongoing lung cancer studies to
increase the power for subgroup analysis. The consortium
was established with funding from the National Cancer Insti-
tute (NCI) and the IARC. Investigators with eligible epide-
miologic studies of lung cancer were invited to participate in
the ILCCO data pooling project. A total of 56 lung cancer
studies have each provided a study protocol for subject
recruitment and a structured questionnaire for lifestyle infor-
mation to participate in ILCCO. Details of the studies have
been reported previously.11–20
Eighteen case–control studies in ILCCO provided the data
for this analysis, all measured through structured question-
naires (Table 1). Eight studies were conducted in North
America; four studies were conducted in Europe; and six
studies were conducted in Asia/Oceania. Eight studies
recruited healthy controls from the general population; eight
studies recruited controls from hospital patients or their fam-
ily or friends who did not have any smoking-related illnesses;
and two studies recruited controls from mixed sources. Fif-
teen studies matched cases with controls on potential con-
founders, such as age, sex, and ethnicity, while three studies
did not use matching. Written informed consents were
obtained from all study participants, and each study was
approved by its respective local human subject review board.
The most commonly used deﬁnition of never smokers was
those who smoked less than 100 cigarettes in their lifetime
(the FHS, UCLA, WELD, NELCS, SLRI, Harvard, Mayo, and
IARC studies). Other deﬁnitions included those who smoked
less than 180 cigarettes in their lifetime (the Hawaii study),
those who smoked less than 200 cigarettes in their lifetime
(the Seoul study), those who smoked less than 365 cigarettes
in their lifetime (the Kyushu, Mofﬁtt, and GEL-S studies),
those who never smoked more than ten cigarettes per week
regularly (the Liverpool study), or those who either smoked
less than 400 cigarettes in their lifetime or less than one ciga-
rette per day for 1 year (the CREST study). The Aichi and
GenAir studies deﬁned never smokers as those who reported
they had never smoked.
We checked the data for inadmissible values, aberrant dis-
tributions, inconsistencies, and missing values and sent
queries to the participating investigators to resolve all issues.
We excluded from the analysis participants with unknown
age (n 5 31) or race/ethnicity (n 5 251). We also excluded
10,442 participants with unknown secondhand smoke expo-
sure status, of whom 7,541 were from the IARC, Mofﬁt, or
GenAir study. The IARC and Mofﬁtt studies collected infor-
mation regarding secondhand smoke exposure from never
smokers only, and the GenAir study collected information
regarding secondhand smoke exposure from those who either
never smoked or who had stopped smoking for at least 10
years. The cases and controls excluded due to unknown
exposure status had similar distributions of age, sex, and
race/ethnicity as those included in the analysis.
The data for this study included 12,688 lung cancer cases
and 14,452 controls, of whom 2,504 cases and 7,276 controls
were never smokers and 10,184 cases and 7,176 controls were
current or former smokers. Cases included patients with
invasive tumors of the lung using either the International
Classiﬁcation of Diseases for Oncology (ICD-O) version 2 or
the International Classiﬁcation of Diseases (ICD), Ninth or
Tenth Edition.
Statistical analysis
We performed unconditional logistic regression to obtain
odds ratios (OR) with 95% conﬁdence intervals (CI) to
assess the association between exposure to secondhand
smoke and lung cancer risk. All models included age (con-
tinuous), sex, race/ethnicity (White/Caucasian, Latino,
Black/African-American, Asian, Native American, or other),
and study center. We examined the joint effects of active
smoking and exposure to secondhand smoke and tested for
multiplicative interaction. We assessed various aspects of
secondhand smoke exposure, including location, duration,
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and childhood exposure. Exposure duration variables
included duration of exposure at home, duration of expo-
sure at the workplace, and duration of exposure at home
and work combined. The combined duration of exposure
variable was created by summing the values for duration of
exposure at home and duration of exposure at work—thus,
it is the maximum possible duration of exposure, since there
could be overlap between exposure periods. We performed
the analyses among the total sample and among never
smokers separately. For analyses among the total sample, we
further adjusted the models for cigarette smoking status
(ever smoker or never smoker) and pack-years of cigarette
smoking (continuous) to separate the qualitative difference
between ever smokers and never smokers from the quantita-
tive impact of smoking.21 The subanalysis of never smokers
allowed us to completely eliminate the confounding effect of
active smoking, assuming there was no misclassiﬁcation of
ever/never smoking status.
We tested for heterogeneity across the study odds ratios
by using the likelihood ratio test, in which we examined the
difference between the log likelihood of a model with the
product term between study and the variable of interest, and
Table 1. Summary of studies pooled
Project/institute by
region Study name Principal investigator Control source Study period Study location
North America
Family Health Study FHS A.G. Schwartz Population 1984–1987,
1990–2003
Detroit, MI, USA
University of
California at Los
Angeles
UCLA Z.F. Zhang Population 1999–2004 Los Angeles, CA, USA
Women’s
Epidemiology of Lung
Disease
WELD A.G. Schwartz Population 2001–2005 Detroit, MI, USA
New England Lung
Cancer Study
NELCS E. Duell Population 2005–2008 New Hampshire and
Vermont, USA
Samuel Lunenfeld
Research Institute
SLRI J. McLaughlin Mixed 1997–2002 Toronto, Canada
Harvard Harvard D. Christiani Hospital 1992–2008 Boston, MA, USA
Mayo Clinic Mayo P. Yang Hospital 1997–2006 USA
Moffitt Moffitt P. Lazarus Hospital 1999–2003 Florida, USA
Europe
European Prospective
Investigation into
Cancer and Nutrition
GenAir P. Vineis Population 1993–1998 10 European
countries
Cancer of the
Respiratory Tract
Biorepository
CREST M. Neri Mixed 1996–present Northern Italy
Liverpool Lung
Project
Liverpool J. Field Population 1998–2016 Liverpool, UK
International Agency
for Research on
Cancer
IARC P. Boffetta Hospital 1998–2002 Central/Eastern
Europe
Asia and Oceania
University of Hawaii Hawaii L. Le Marchand Population 1992–1997 Hawaii, USA
Kyushu University Kyushu C. Kiyohara Population 1994–1996 Japan
Genes and
Environment in Lung
Cancer, Singapore
GEL-S 1 A. Seow Hospital 1996–1998 Singapore
Genes and
Environment in Lung
Cancer, Singapore
GEL-S 2 A. Seow Hospital 2005–2007 Singapore
Aichi Cancer Center Aichi K. Tajima/K. Mastuo Hospital 2001–2005 Aichi, Japan
Seoul University Seoul Y.C. Hong Hospital 2001–2008 Seoul, Korea
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that of a model without such a product term. When there
was evidence of heterogeneity in the study-speciﬁc odds
ratios, we assessed the source of heterogeneity by stratiﬁed
analyses. If the heterogeneity was not due to any study char-
acteristic, we examined forest plots and performed inﬂuence
analysis to assess the source of heterogeneity from any single
study. For inﬂuence analysis, each study was excluded one at
a time to assure that the magnitude of the overall summary
estimate and p value were not dependent on any one study.
We also conducted separate analyses by lung cancer his-
tology to compare the estimated associations of secondhand
smoke with different histological subtypes. We combined
bronchioloalveolar carcinomas with the rest of the adenocar-
cinomas; excluding them had negligible effect on the results.
When comparing small cell lung cancer with nonsmall cell
lung cancers, we employed a case–case approach.22,23 All sta-
tistical analyses were performed with SAS v9.3. All p values
are two-sided.
Results
The distributions of basic characteristics of the lung cancer
patients and controls among the overall population and
among the subsample of never smokers are shown in Table
2. The contribution of cases from the individual studies
ranged from 1 to 33% and that of controls ranged from 1 to
16%. The majority of the cases and controls lived in North
America. In both the overall population and the never
smoker population, the proportion of older participants (65
years or above) was higher among the cases than among the
controls. The proportion of men was higher in cases than in
controls among the overall population, but lower among the
never smoker population. The proportion of adenocarcinoma
was higher among never smokers than among the overall
population; the proportions of squamous cell carcinoma and
small cell carcinoma were lower among never smokers than
among the overall population; the proportions of large cell
lung cancer were similar between the two populations.
Table 3 shows the joint effects of active smoking and
exposure to secondhand smoke. Exposure to secondhand
smoke was associated with an increased risk of lung cancer
among both ever smokers and never smokers, and multiplica-
tive interaction was observed between active smoking and
exposure to secondhand smoke (ratio of odds ratios [ROR]
5 1.33, 95% CI: 1.15–1.54).
Table 4 reports the associations between exposure to sec-
ondhand smoke and lung cancer by histological subtype in the
overall study population. Compared with those never exposed
to secondhand smoke, those ever exposed were at a higher
risk of lung cancer (OR 5 1.34, 95% CI: 1.24–1.45). Positive
associations were also observed when the different histological
types of lung cancer were considered separately (OR 5 1.35,
95% CI: 1.23–1.48 for adenocarcinoma; OR 5 1.36, 95% CI:
1.17–1.58 for squamous cell carcinoma; OR 5 1.36, 95% CI:
1.04–1.79 for large cell lung cancer; and OR 5 1.63, 95% CI:
1.31–2.04 for small cell lung cancer). Associations seemed to
differ by exposure location. No association was observed for
those exposed at work (OR 5 1.02, 95% CI: 0.93–1.13), but
positive associations were observed for those exposed at home
(OR 5 1.19, 95% CI: 1.08–1.31) and those exposed both at
home and at work (OR 5 1.39, 95% CI: 1.27–1.52). However,
there was heterogeneity across the studies (p < 0.001). Risk of
lung cancer increased with increasing years of exposure at
home (p < 0.001), at work (p 5 0.02), and at home and work
combined (p 5 0.002). Positive associations were also detected
for exposure during childhood when all histological types were
combined (OR 5 1.15, 95% CI: 1.05–1.25) and when small
cell lung cancer was examined separately (OR 5 1.35, 95% CI:
1.09–1.67). The positive association between exposure during
childhood and lung cancer development persisted when all
types of nonsmall cell lung cancer were combined (OR 5
1.12, 95% CI: 1.02–1.23; results not shown).
Stratiﬁed analyses showed that the associations between
exposure to secondhand smoke and lung cancer development
did not differ signiﬁcantly by sex (OR 5 1.23, 95% CI:
1.10–1.38 for males; OR 5 1.37, 95% CI: 1.23–1.52 for
females; results not shown) or race/ethnicity (OR 5 1.43,
95% CI: 1.30–1.58 for Whites; OR 5 1.16, 95% CI: 1.00–1.34
for Asians; OR 5 0.99, 95% CI: 0.60–1.64 for Blacks; OR 5
0.75, 95% CI: 0.43–1.32 for Hispanic/Latinos; results not
shown). When we stratiﬁed the overall population by age
(<65 years old and 65 years old), positive associations were
observed in both age groups (OR 5 1.22, 95% CI: 1.09–1.36
for <65 years old; OR 5 1.45, 95% CI: 1.30–1.63 for 65
years old; results not shown).
Table 5 presents the associations between exposure to sec-
ondhand smoke and lung cancer by histological type among
never smokers only. Exposure to secondhand smoke was associ-
ated with an increased risk of lung cancer in this population as
well (OR 5 1.31, 95% CI: 1.17–1.47). Positive associations were
observed for all of the histological types examined, with the
strongest association observed for small cell lung cancer (OR 5
1.26, 95% CI: 1.10–1.44 for adenocarcinoma; OR 5 1.41, 95%
CI: 0.99–1.99 for squamous cell carcinoma; OR 5 1.48, 95%
CI: 0.89–2.45 for large cell lung cancer; OR 5 3.09, 95% CI:
1.62–5.89 for small cell lung cancer). Exposure at home seemed
to have a greater inﬂuence than exposure at work—the adjusted
odds ratios were 1.21 (95% CI: 1.05–1.39) for those exposed at
home, 1.10 (95% CI: 0.94–1.28) for those exposed at work, and
1.30 (95% CI: 1.12–1.50) for those exposed both at home and
at work. Lung cancer risk tended to increase with increasing
years of exposure (p 5 0.07 for exposure at home; p 5 0.08 for
exposure at work; p 5 0.04 for exposure at home and work
combined). We did not observe an apparent association
between lung cancer risk and childhood exposure to second-
hand smoke (OR 5 1.08, 95% CI: 0.92–1.26).
Associations between exposure to secondhand smoke and
lung cancer development among never smokers were similar
in males versus females (OR 5 1.35, 95% CI: 1.07–1.71 for
males; OR 5 1.27, 95% CI: 1.11–1.45 for females; results not
shown). There was some indication of heterogeneity of
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Table 2. Distribution of characteristics of the overall population and never smokers
All Never smokers
Cases, n (%) Controls, n (%) p value1 Cases, n (%) Controls, n (%) p value1
Total 12,688 14,452 2,504 7,276
study
FHS 979(7.72) 1,173(8.12) <0.0001 377(15.06) 678(9.32) <0.0001
UCLA 609(4.80) 1,038(7.18) 109(4.35) 470(6.46)
WELD 571(4.50) 571(3.95) 52(2.08) 279(3.83)
NELCS 276(2.18) 251(1.74) 11(0.44) 95(1.31)
SLRI 439(3.46) 928(6.42) 152(6.07) 455(6.25)
Harvard 2,119(16.70) 1,517(10.50) 135(5.39) 479(6.58)
Mayo 4,192(33.04) 2,235(15.46) 635(25.36) 812(11.16)
Moffitt 117(0.92) 384(2.66) 39(1.56) 303(4.16)
GenAir 74(0.58) 702(4.86) 47(1.88) 466(6.40)
CREST 401(3.16) 551(3.81) 45(1.80) 237(3.26)
Liverpool 286(2.25) 888(6.14) 17(0.68) 247(3.39)
IARC 255(2.01) 1,012(7.00) 198(7.91) 831(11.42)
Hawaii 628(4.95) 587(4.06) 45(1.80) 224(3.08)
Kyushu 190(1.50) 108(0.75) 59(2.36) 57(0.78)
GEL-S 1 261(2.06) 674(4.66) 149(5.95) 585(8.04)
GEL-S 2 367(2.89) 748(5.18) 228(9.11) 642(8.82)
Aichi 453(3.57) 815(5.64) 117(4.67) 319(4.38)
Seoul 471(3.71) 270(1.87) 89(3.55) 97(1.33)
Region
North America 9,930(78.26) 8,684(60.09) <0.0001 1,555(62.10) 3,795(52.16) <0.0001
Europe 1,016(8.01) 3,153(21.81) 307(12.26) 1,781(24.48)
Asia/Oceania 1,742(13.73) 2,615(18.09) 642(25.64) 1,700(23.36)
Age (years)
<45 1,021(8.05) 2,117(14.65) <0.0001 285(11.38) 1,154(15.86) <0.0001
45–49 898(7.08) 1,230(8.51) 209(8.35) 674(9.26)
50–54 1,096(8.64) 1,608(11.13) 255(10.18) 842(11.57)
55–59 1,609(12.68) 2,002(13.85) 300(11.98) 995(13.68)
60–64 1,763(13.90) 1,949(13.49) 306(12.22) 900(12.37)
65–69 2,181(17.19) 2,035(14.08) 387(15.46) 1,003(13.79)
70 4,120(32.47) 3,511(24.29) 762(30.43) 1,708(23.47)
Sex
Men 6,378(50.27) 6,587(45.58) <0.0001 597(23.84) 2,308(31.72) <0.0001
Women 6,310(49.73) 7,865(54.42) 1,907(76.16) 4,968(68.28)
Ethnicity
Non-Hispanic White 9,478(74.70) 10,168(70.36) <0.0001 1,543(61.62) 4,696(64.54) <0.0001
Asian 2,131(16.80) 3,066(21.22) 766(30.59) 1,954(26.86)
Black/African-American 540(4.26) 627(4.34) 100(3.99) 330(4.54)
Hispanic/Latino 114(0.90) 261(1.81) 44(1.76) 132(1.81)
Native American 218(1.72) 47(0.33) 25(1.00) 16(0.22)
Other 207(1.63) 283(1.96) 26(1.04) 148(2.03)
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associations by race/ethnicity, but the sample sizes were not
large enough to obtain precise estimates for non-White popu-
lations (OR 5 1.36, 95% CI: 1.18–1.58 for Whites; OR 5
1.20, 0.98–1.45 for Asians; OR 5 0.52, 0.25–1.06 for Blacks;
OR 5 1.57, 0.70–3.52 for Hispanic/Latinos; results not shown).
A stronger association was observed within the older age
group of never smokers than within the younger age group
(OR 5 1.56, 95% CI: 1.31–1.86 for 65 years old; OR 5 1.10,
95% CI: 0.95–1.29 for <65 years old; results not shown).
Table 6 compares small cell lung cancer with nonsmall
cell lung cancer in terms of their association with second-
hand smoke exposure. The adjusted odds ratios comparing
small cell lung cancer with nonsmall cell lung cancer were
1.28 (95% CI: 1.03–1.59) and 2.11 (95% CI: 1.11–4.04) in the
overall population and among never smokers, respectively.
Discussion
This pooled analysis is the largest collaborative effort investi-
gating the association between exposure to secondhand
smoke and the development of lung cancer by histological
type. Exposure to secondhand smoke was associated with an
increased risk of lung cancer among both ever smokers and
never smokers. Among the overall population, exposure to
secondhand smoke increased the risk of lung cancer by
approximately 30 and 60% for nonsmall cell lung cancer and
small cell lung cancer, respectively. Among never smokers,
secondhand smoke exposure increased the risk by approxi-
mately 30 and 200% for nonsmall cell lung cancer and small
cell lung cancer, respectively.
Results of our joint effects analyses suggest that exposure
to secondhand smoke is associated with lung cancer risk in
both ever smokers as well as never smokers. The strong asso-
ciation between secondhand smoke exposure and lung cancer
risk among ever smokers might be related to the fact that
smokers exposed to secondhand smoke tend to smoke more
than unexposed smokers do, as was the case in the present
analysis—the mean pack-years of smoking was 42.3 among
those exposed to secondhand smoke, compared with 34.5
among those who were unexposed (t test p < 0.0001; results
not shown). However, the association was very strong even
after adjusting for pack-years of smoking (OR 5 1.40, 95%
CI: 1.25–1.56; results not shown). Therefore, a potential alter-
native explanation for this ﬁnding is that mainstream smoke
and sidestream smoke have a synergistic effect on lung can-
cer development.
Our results also indicate that the association with second-
hand smoke exposure may be greater for small cell lung can-
cer than for the other histological types (p 5 0.02). This
observation is consistent with the point estimates reported in
previous studies by Hackshaw et al. and Brennan et al. which
Table 2. Distribution of characteristics of the overall population and never smokers (Continued)
All Never smokers
Cases, n (%) Controls, n (%) p value1 Cases, n (%) Controls, n (%) p value1
Histology
Adenocarcinoma 6,006(47.34) 1,555(62.10)
Squamous cell carcinoma 2,599(20.48) 211(8.43)
Large cell 653(5.15) 95(3.79)
Other nonsmall cell 790(6.23) 91(3.63)
Small cell 1,177(9.28) 79(3.15)
Other/mixed/missing 1,463(11.53) 473(18.89)
1p values are for v2 tests comparing cases and controls.
Table 3. Joint effects of active smoking and exposure to secondhand smoke on lung cancer risk
Active smoking Exposed to secondhand smoke Cases Controls Unadjusted OR (95% CI) Adjusted OR1 (95% CI)
Never Never 651 2,167 1.00 Reference 1.00 Reference
Never Ever 1,817 4,890 1.24 (1.12–1.37) 1.27 (1.14–1.42)
Ever Never 1,219 1,074 3.78 (3.35–4.26) 2.83 (2.48–3.22)
Ever Ever 8,827 5,921 4.96 (4.52–5.45) 4.79 (4.32–5.32)
Adjusted ratio of odds ratios1 (95% CI)
Overall: 1.33 (1.15–1.54)
Adenocarcinoma: 1.44 (1.20–1.72)
Squamous cell carcinoma: 1.12 (0.78–1.59)
Large cell lung cancer: 1.13 (0.64–2.01)
Small cell lung cancer: 0.79 (0.42–1.50)
1Odds ratios adjusted for age, sex, race/ethnicity, and study.
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also evaluated the association between secondhand smoke
exposure and lung cancer risk, but with small and squamous
cell carcinomas combined.6,7 Detecting such clear associations
has been particularly challenging for small cell lung cancer
due to the small number of cases among never smokers. In
our study, the difference in the magnitudes of the association
among the overall population compared with never smokers
may be due to chance or residual confounding.
Epidemiologic studies have consistently reported that ciga-
rette smoking is most strongly associated with small cell lung
cancer, followed by squamous cell carcinoma.3,10,23–28 The dif-
ferences in the strengths of associations by histological type is
thought to be related to tumor location. Small cell lung can-
cer and squamous cell carcinoma mainly occur in the large
central bronchi whereas adenocarcinoma and large cell lung
cancer arise from more peripheral sites. The aerodynamic
diameters of cigarette smoke particles determine the sites of
deposition in the regions of the lung.29 It has been hypothe-
sized that sites that are more proximal in the respiratory tract
are more heavily exposed to tobacco smoke particles, espe-
cially those of larger size, than are peripheral sites.25,30,31 De
Stefani et al. suggested that the presence of carcinogenic radi-
oactive compounds and heavy metals in tobacco smoke could
also explain the strong relation between exposure to tobacco
smoke and small cell lung cancer, since occupational exposure
to these carcinogens are strongly associated with small cell
lung cancer.23 Many of these carcinogens (e.g., nickel, chro-
mium, and arsenic) are also major constituents of sidestream
smoke.5 The results of our study suggest that cigarette smoke
plays a major role in the development of small cell lung can-
cer not only in the form of mainstream smoke affecting active
smokers but also in the form of sidestream smoke affecting
both active and passive smokers.
Lung cancer histology seems to be dictated by genetic
alterations and the type of cells in which they occur. In a
study using precise laser capture microdissection and allelo-
typing, Wistuba et al. reported there were differences in spe-
ciﬁc genetic alterations detected in small cell lung cancer
compared with nonsmall cell lung cancers, and the smoking-
damaged bronchial epithelium of patients with small cell
lung cancer showed considerably more genetic damage—in
terms of allele loss and microsatellite alterations—than that
of patients with nonsmall cell lung cancers.32 Furthermore,
many genetic alterations were also frequently observed in his-
tologically normal and mildly abnormal bronchial biopsies
from current and former smokers.32 Rb and p53 mutations,
which occur in up to 90% of human small cell lung cancers,
are examples of genetic damage caused by smoking. In a
study to establish a mouse model for small cell lung cancer,
Meuwissen et al. demonstrated that concomitant loss of Rb
and p53 in a broad range of mouse lung epithelial cells gave
rise almost exclusively to small cell lung cancer.33 Although
the cellular origin of lung cancer is largely unknown, it is
speculated that different histological types arise from distinct
cells of origin located in deﬁned microenvironments, andTa
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small cell lung cancer is thought to have its origin in neuro-
endocrine cells.33–35
We also observed some variations in strengths of associations
by the location and duration of secondhand smoke exposure.
Exposure at home seemed to have a stronger effect than expo-
sure at the workplace, probably because exposure at home—
especially from a spouse—is more likely to be of greater duration
and intensity than exposure at work. The results also suggest
that people exposed to secondhand smoke both at home and at
the workplace are more likely to develop lung cancer than those
exposed at one location only. For both exposure at home and
exposure at work, we observed dose–response relations between
duration of exposure and lung cancer incidence. The trends
were more evident among the overall population than among
the subgroup of never smokers, possibly due to the difference in
sample sizes. Brennan et al. also reported such dose–response
relations among never smokers, but their method of categorizing
duration of exposure differed from ours.7 When we used the
same duration categories used by Brennan et al. (<16/16–30.9/
31.0 years for exposure from the spouse—assumed to be com-
parable to our variable for exposure at home—and <8.0/8.0–
20.9/21.0 years for exposure at work), we observed dose–
response relations among never smokers for both exposure at
home (p 5 0.04) and exposure at work (p 5 0.02). Lastly, expo-
sure to secondhand smoke during childhood was associated
with lung cancer among the overall population. Results from
previous studies of exposure to secondhand smoke during child-
hood have been inconsistent, which could be, at least partially,
due to the difﬁculty of recalling exposures that took place a long
time ago.36–49 The inconsistency may also be due to chance,
since some studies had low power.
This study has several limitations. Due to the nature of our
case–control study design, the results might be inﬂuenced to
some degree by recall bias. Since tobacco is an established risk
factor for many diseases, hospital-based controls might be
more likely than healthy controls to recall their exposure to
secondhand smoke. If this is in fact the case, our results from
hospital-based case–control studies might be more likely to be
biased towards the null, compared to those from population-
based studies. However, when we performed stratiﬁed analysis,
the association between exposure to secondhand smoke and
lung cancer development was even stronger within the stratum
of hospital-based studies than that of population-based studies.
Variations in the deﬁnition of never smokers across studies
could also be a limitation. However, consistent results from
inﬂuence analysis conﬁrmed that the observed associations
were not due to any particular study. Another potential source
of bias might be the result of misclassiﬁcation of ever smokers
as never smokers due to misreporting. In addition, the con-
cordance of smoking status within couples might lead to bias
of the estimates. Although we were not able to assess this issue
in this pooled population, a European validation study has sug-
gested that such bias from smoker misclassiﬁcation is not likely
to be signiﬁcant.50 If a disproportionate number of exposed
controls had been classiﬁed as unexposed, then this might biasTa
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the estimated association away from the null. Finally, we
excluded some participants from the analysis due to missing
data, mostly on exposure status. Selection bias is possible if the
data were not missing at random. However, comparing those
excluded from the analysis with those included, the distribu-
tions of the covariates were similar between the two groups,
except for study site.
The strength of this study is the relatively high power
achieved through the pooling of individual-level data. Com-
pared with meta-analyses, pooled analyses such as ours can
achieve high power with less publication bias and more con-
sistent covariate adjustment. Although our results point to
the role of secondhand smoke in the development of lung
cancer regardless of histological type, the extent of the rela-
tionship varies by histological type and is especially strong
for small cell lung cancer.
While it is important to disseminate the public health
message about the hazard of active and passive smoking in
order to reduce the incidence of lung cancer, further investi-
gation on the etiologic processes underlying the association
between tobacco smoke and lung cancer are warranted.
Future studies should also determine if exposure to second-
hand smoke is associated with stage of lung cancer, as well as
consider other potential risk factors, including indoor air pol-
lution from other sources and genetic factors. In the ILCCO
consortium, we have started the process of pooling genetic
data in order to investigate the role of genetic polymorphisms
in the DNA repair genes in the development of lung cancer
among never smokers.
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Table 6. Difference of associations with exposure to secondhand smoke between small cell lung cancer and nonsmall cell lung cancer
Histological type Cases Controls
Unadjusted Adjusted2
OR (95% CI) OR1 (95% CI) OR (95% CI) OR1 (95% CI)
Overall population
Nonsmall cell lung cancer 9,941 14,052 1.72 (1.61–1.84) 1.00 1.34 (1.23–1.46) 1.00
Small cell lung cancer 1,156 14,052 2.04 (1.71–2.44) 1.19 (0.99–1.43) 1.63 (1.31–2.04) 1.28 (1.03–1.59)
Histological type Cases Controls
Unadjusted Adjusted3
OR (95% CI) OR1 (95% CI) OR (95% CI) OR1 (95% CI)
Never smokers
Nonsmall cell lung cancer 1,931 7,057 1.20 (1.07–1.35) 1.00 1.28 (1.13–1.45) 1.00
Small cell lung cancer 78 7,057 2.22 (1.22–4.03) 1.84 (1.01–3.37) 3.09 (1.62–5.89) 2.11 (1.11–4.04)
1Odds ratio for developing small cell lung cancer compared with nonsmall cell lung cancer with respect to exposure to secondhand smoke, using
case-case study methods.
2Odds ratio adjusted for age, sex, race/ethnicity, study, smoking status, and pack-years of smoking.
3Odds ratio adjusted for age, sex, race/ethnicity, and study.
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